Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates

Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates GlobeNewswire August 06, 2025 – On track for proof-of-concept Phase 1b data no later than this fall in participants with recurrent genital herpes for long-acting herpes simplex virus (HSV) helicase-primase inhibitor candidates, ABI-5366 and ABI-1179 – – Positive topline data reported for Phase 1b […]

Berkshire Hills Bancorp and Brookline Bancorp to be Combined as Beacon Financial Corporation and Beacon Bank Upon the Closing of their Merger of Equals

(NASDAQ:BRKL), BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Berkshire Hills Bancorp, Inc. (“Berkshire”) (NYSE: BHLB), the parent company of Berkshire Bank, and Brookline Bancorp, Inc. (“Brookline”) (NASDAQ: BRKL), the parent company of Brookline Bank, Bank Rhode Island, and PCSB Bank, today announced that the combined holding company that will be created through their transformative merger

Talkspace to Participate in Upcoming Investor Conference

Talkspace to Participate in Upcoming Investor Conference GlobeNewswire August 06, 2025 NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the Canaccord Genuity 45th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results GlobeNewswire August 06, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress

Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference

(NasdaqGM:GUTS), BURLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the second quarter 2025 and provide business updates on

BBSI Reports Strong Second Quarter 2025 Financial Results

(NASDAQ:BBSI), – Revenues and Gross Billings up 10% to $307.7 Million and $2.23 Billion –– Announces New $100 Million Stock Repurchase Program – VANCOUVER, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management solutions, reported financial results for the second quarter

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Cytek Biosciences Reports Second Quarter 2025 Financial Results GlobeNewswire August 06, 2025 FREMONT, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — Cytek(R) Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2025. Second Quarter Highlights Total revenue for the second

Encore Capital Group Announces Second Quarter 2025 Financial Results

Encore Capital Group Announces Second Quarter 2025 Financial Results GlobeNewswire August 06, 2025 Favorable purchasing conditions continue in U.S. market Global portfolio purchases up 32% to $367 million, including record $317 million in U.S. Global collections up 20% to record $655 million, including record $490 million in U.S. Estimated remaining collections (ERC) up 12% to

electroCore Announces Second Quarter 2025 Financial Results

(NASDAQ:ECOR), Net sales of $7.4 million increased 20% vs. Q2'2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024 Cash, cash equivalents, restricted cash, and marketable securities of $7.4 million as of June 30, 2025 Company to host a conference call and webcast today, August 6, 2025, at 4:30 p.m. EDT

AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance

AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance GlobeNewswire August 06, 2025 Dr. Tarnoff brings extensive executive and medical leadership experience from various organizations, including Tufts Medical Center and Medtronic. The Board thanks Lou Panaccio, its long-standing Board Chair, for

Scroll to Top